Sage Therapeutics

Read more
Barry E. Greene's photo - CEO of Sage Therapeutics

CEO

Barry E. Greene

CEO Approval Rating

83/100

Founded:

2010

Status:

PublicIndependent CompanyNASDAQSAGE

SAGE THERAPEUTICS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Praxis Precision Medicines Inc is one of Sage Therapeutics's top rivals. Praxis Precision Medicines Inc was founded in Cambridge, Massachusetts} in 2015. Like Sage Therapeutics, Praxis Precision Medicines Inc also competes in the Pharmaceuticals space. Compared to Sage Therapeutics, Praxis Precision Medicines Inc generates $ less revenue.

Axsome Therapeutics is Sage Therapeutics's #2 competitor. Axsome Therapeutics was founded in 2012, and is headquartered in New York, New York. Like Sage Therapeutics, Axsome Therapeutics also operates in the Pharmaceuticals space. Axsome Therapeutics generates $1.1B less revenue vs. Sage Therapeutics.

Sage Therapeutics Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$1.1B

Sage Therapeutics's revenue is the ranked 1st among it's top 10 competitors. The top 10 competitors average 557M. Over the last four quarters, Sage Therapeutics's revenue has grown by 45.4%. Specifically, in Q1 2021's revenue was $1.6M; in Q4 2020, it was $1.1B; in Q3 2020, it was $1.6M; in Q2 2020, Sage Therapeutics's revenue was $1.1M.

Sage Therapeutics Acquisitions

No recent acquisitions found related to Sage Therapeutics

Sage Therapeutics Funding History

Since Sage Therapeutics was founded in 2010, it has participated in 6 rounds of funding. In total Sage Therapeutics has raised $843.0M. Sage Therapeutics' last funding round was on Dec 2020 for a total of $650.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Post-IPO Equity
Dec 2020
$650M
-
IPO
Jul 2014
$90M

Series C
Mar 2014
$38M
Equity
Jan 2014
$10M
-
Series B
Oct 2013
$20M

Since Sage Therapeutics was founded in 2010, it has participated in 6 rounds of funding. In total Sage Therapeutics has raised $843.0M. Sage Therapeutics' last funding round was on Dec 2020 for a total of $650.0M

Sage Therapeutics Investments

No recent investments found related to Sage Therapeutics

Sage Therapeutics News

Sage Therapeutics Press Releases

Social Media

Sage Therapeutics Headquarters

215 First Street

Cambridge, Massachusetts02142

1-617-299-8380

Driving Directions »

Trending Companies

Sage Therapeutics Summary

ABOUT

Overview

Sage Therapeutics is a biotechnology firm that develops and commercializes novel therapies for the treatment of CNS and neurodegenerative disorders. Sage Therapeutics was founded in 2010. Sage Therapeutics' headquarters is located in Cambridge, Massac...

CEO

Sage Therapeutics's CEO, Barry E. Greene, currently has an approval rating of 83%. Sage Therapeutics's primary competitors are Praxis Precision Medicines Inc, Axsome Therapeutics &

Website

sagerx.com

Frequently Asked Questions about Sage Therapeutics

  1. When was Sage Therapeutics founded?

    Sage Therapeutics was founded in 2010
  2. Who is Sage Therapeutics's CEO?

    Sage Therapeutics's CEO is Barry E. Greene
  3. How much revenue does Sage Therapeutics generate?

    Sage Therapeutics generates $1.1B in revenue
  4. How much funding does Sage Therapeutics have?

    Sage Therapeutics has historically raised $843M in funding
  1. Where is Sage Therapeutics's headquarters?

    Sage Therapeutics's headquarters is in Cambridge Massachusetts, USA
  2. How many employees does Sage Therapeutics have?

    Sage Therapeutics has 637 employees
  3. What sector does Sage Therapeutics operate in?

    Sage Therapeutics is in Pharmaceuticals, Biotechnology
  4. Who are Sage Therapeutics's competitors?

    Sage Therapeutics's top competitors are Praxis Precision Medicines Inc, Axsome Therapeutics